InvestorsHub Logo
Followers 2
Posts 998
Boards Moderated 0
Alias Born 06/02/2012

Re: None

Wednesday, 05/10/2017 11:41:20 PM

Wednesday, May 10, 2017 11:41:20 PM

Post# of 15242
Roche's bladder cancer drug failed in phase 3 testing. With over 900 patients enrolled, maybe this is why the CG0070 trial was not able to achieve full enrollment. Cold Genesys presents CG0070 results at the AUA Conference on Monday.

Tecentriq Clinical Trial
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ANIP News